- Home
- POLA vs MYNZ Comparison
POLA vs MYNZ Comparison
Compare POLA & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | POLA | MYNZ |
|---|---|---|
| Founded | 1979 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0M | 8.8M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | POLA | MYNZ |
|---|---|---|
| Price | $1.87 | $1.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 22.7K | ★ 191.0K |
| Earning Date | 11-19-2025 | 12-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,326,000.00 | $659,935.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.53 | $0.92 |
| 52 Week High | $5.75 | $8.20 |
Technical Indicators
Market Signals| Indicator | POLA | MYNZ |
|---|---|---|
| Relative Strength Index (RSI) | 28.77 | 54.02 |
| Support Level | $2.15 | $1.00 |
| Resistance Level | $2.23 | $1.15 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 11.61 | 76.27 |
Price Performance
Historical ComparisonAbout POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.